| 2024-02-29 | United States | Settlement | United States Reaches Settlement Of Law Enforcement, Tax, And Healthcare Cost Claims In Endo International Bankruptcy Case U.S. Department of Justice | — |
| 2024 | United States | Settlement | In 2024, Endo agreed to a civil settlement of $464.9 million to resolve its civil liability under the federal False Claims Act by unlawfully promoting Opana ER, a dangerous opioid drug that was remove Wikipedia: Endo International（Lawsuits） | $464.9 million |
| 2022 | United States | Settlement | As part of Endo's 2022 bankruptcy proceedings, it agreed to spend more than $500 million settling opiod relating lawsuits. These proceedings now require Endo to turn over all court documents related t Wikipedia: Endo International（Lawsuits） | $500 million |
| 2021 | United States | Filed / under investigation | In 2021, New York Attorney General Letitia James filed a lawsuit against Endo and several other opioid manufacturers for their alleged contribution to the opioid epidemic in New York. Wikipedia: Endo International（Lawsuits） | — |
| 2020-12-01 | United States | Filed / under investigation | Prescription Opioid Cases California Court of Appeal | — |
| 2020-11-25 | United States | Judgment for company / dismissed | Prescription Opioid Cases California Court of Appeal | — |
| 2019-02-04 | United States | Filed / under investigation | State of Delaware, ex rel. Jennings v. Purdue Pharma L.P. Superior Court of Delaware | — |
| 2018 | United States | Settlement | In 2018, Endo paid $200 million to settle over 1,200 lawsuits related to its testosterone replacement therapy, Testim, and its undisclosed side effects. Wikipedia: Endo International（Lawsuits） | $200 million |
| 2017 | United States | Warning letter / order | On June 8, 2017, the U.S. Food and Drug Administration (FDA) released a press statement in which it announced that it requested Endo to withdraw its opioid drug, oxymorphone hydrochloride (Opana ER), Wikipedia: Endo International（Lawsuits） | — |
| 2016 | United States | Other | After facing lawsuits over its production of vaginal mesh implants, Endo shut down its production in 2016 to avoid further litigation It had set aside more than $2.6 billion to payments for such cases Wikipedia: Endo International（Lawsuits） | $2.6 billion |
| 2016 | United States | Filed / under investigation | Endo is one of the companies named in lawsuits by the states of Ohio, Missouri and Mississippi as responsible for the US opioid epidemic . Its 10-K statement indicates that a majority of the company's Wikipedia: Endo International（Lawsuits） | — |
| 2015-05-05 | United States | Filed / under investigation | In re Lidoderm Antitrust Litigation District Court, N.D. California | — |
| 2014-11-17 | United States | Filed / under investigation | United Food & Commercial Workers Local 1776 v. Teikoku Pharma USA, Inc. District Court, N.D. California | — |
| 2014-06-23 | United States | Filed / under investigation | United States ex rel. Ryan v. Endo Pharmaceuticals, Inc. District Court, E.D. Pennsylvania + 1 more reports | — |
| 2014-02-21 | United States | Settlement | Endo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses U.S. Department of Justice + 3 more reports | $192.7 Million / $20.8 million / $171.9 million |
| 2014-02-21 | United States | Settlement | Endo Health Solutions And Endo Pharmaceuticals Of Malvern, Pa To Pay $171.9 Million To Resolve Civil False Claims Allegations U.S. Department of Justice | $171.9 Million |